Issue 8/2023
Content (40 Articles)
Myeloid sarcoma: more and less than a distinct entity
Giuseppe G. Loscocco, Alessandro M. Vannucchi
Basic mechanisms and novel potential therapeutic targets for ferroptosis in acute myeloid leukemia
Xiao Tang, Yin Wang, Yu Zhu, Yuancheng Guo, Bei Liu
Targeted therapy and immunotherapy for T cell acute lymphoblastic leukemia/lymphoma
Yuan-hong Huang, Chao-Ling Wan, Hai-ping Dai, Sheng-li Xue
Comparison of haploidentical–allogeneic hematopoietic stem cell transplantation and intensive immunosuppressive therapy for patients with severe aplastic anemia with an absolute neutrophil count of zero: a retrospective study
Li-qiang Wu, Li-fang Huang, Hui Yang, Bao-dong Ye, Jian-ping Sheng, Qing-hong Yu, Yan Yang, Jin-song Jia, Dong-hua Zhang, Sheng-yun Lin, Guang-sheng He, Jian-yong Li
Global profile of anemia during pregnancy versus country income overview: 19 years estimative (2000–2019)
Evelyn Araujo Costa, Jackline de Paula Ayres-Silva
Sufficient vitamin D is favorable for children with persistent and chronic immune thrombocytopenia
Rafae El Mabrouk, Dalia Tawfeek Hussein, Mohammed Ezz El Regal Abbas, Suzy Abd El Mabood
Patient preference for deferasirox film-coated versus dispersible tablet formulation: a sequential-design phase 2 study in patients with thalassemia
Vip Viprakasit, Mona M. Hamdy, Hoda M. A. Hassab, Laila M. Sherief, Muneer Al-Bagshi, Mohammed Khattab, Suporn Chuncharunee, Phu Chi Dung, Alphan Küpesiz, Ankita Shekhawat, Yamini Sonawane, Laura Torres Perez, Cassandra Slader, Ali T. Taher
Early initiation of second-line therapy in primary immune thrombocytopenia: insights from real-world evidence
Adam Cuker, Brian Buckley, Marie-Catherine Mousseau, Aditya Anand Barve, Jens Haenig, James B. Bussel
Real-life use of mTOR inhibitor-based therapy in adults with autoimmune cytopenia highlights strong efficacy in relapsing/refractory multi-lineage autoimmune cytopenia
Boris Sorin, Jehane Fadlallah, Margaux Garzaro, Julien Vigneron, Rémi Bertinchamp, David Boutboul, Eric Oksenhendler, Claire Fieschi, Marion Malphettes, Lionel Galicier
N-Acetylcistein for thrombotic thrombocytopenic purpura: an observational case series study
Ignacio Español, Juan Diego Leal, Miguel Blanquer, Faustino García-Candel, Angela Heredia, Joaquín Gómez-Espuch, Celia González, Jorge Montserrat, María Sacramento Díaz-Carrasco, Antonio Martínez, José M. Moraleda
Response and resistance to cladribine in patients with advanced systemic mastocytosis: a registry-based analysis
Johannes Lübke, Nicole Naumann, Georgia Metzgeroth, Sebastian Kreil, Timo Brand, Hans-Peter Horny, Karl Sotlar, Nicholas C. P. Cross, Alice Fabarius, Peter Valent, Wolf-Karsten Hofmann, Andreas Reiter, Juliana Schwaab
Fertility and pregnancy in chronic myeloid leukemia: real-world experience from an Indian tertiary care institution
Chethan R, Prabhat Singh Malik, Ranjit Kumar Sahoo, Surender Sharawat, Mayank Singh, Vikas Garg, Kanupriya Bhatia, Anura Kantak, Sunesh Kumar, Lalit Kumar
Clinical features and current treatment status of essential thrombocythemia in older adults: a multicenter real-world study in China
Rongfeng Fu, Huan Dong, Donglei Zhang, Hu Zhou, Xian Zhang, Yueting Huang, Xiaofan Liu, Feng Xue, Wei Liu, Yunfei Chen, Ting Sun, Mankai Ju, Xinyue Dai, Renchi Yang, Lei Zhang
Therapy results in pediatric Hodgkin lymphoma — does less mean better? Experience from a single children’s oncology center
Joanna Stankiewicz, Andrzej Kołtan, Ewa Demidowicz, Natalia Bartoszewicz, Sylwia Kołtan, Krzysztof Czyżewski, Monika Richert-Przygońska, Robert Dębski, Monika Pogorzała, Barbara Tejza, Joanna Cisek, Piotr Księżniakiewicz, Agnieszka Jatczak-Gaca, Agata Marjańska, Marlena Salamon, Anna Dąbrowska, Anna Urbańczyk, Elżbieta Grześk, Kamila Jaremek, Monika Łęcka, Oliwia Grochowska, Jan Styczyński
Clinical efficacy and tolerability of venetoclax plus rituximab in patients with relapsed or refractory chronic lymphocytic leukemia—a real-world analysis of the Polish Adult Leukemia Study Group
Anita Soboń, Joanna Drozd-Sokołowska, Ewa Paszkiewicz-Kozik, Lidia Popławska, Marta Morawska, Jagoda Tryc-Szponder, Łukasz Bołkun, Justyna Rybka, Katarzyna Pruszczyk, Adrian Juda, Alan Majeranowski, Elżbieta Iskierka-Jażdżewska, Paweł Steckiewicz, Kamil Wdowiak, Bożena Budziszewska, Krzysztof Jamroziak, Iwona Hus, Ewa Lech-Marańda, Bartosz Puła
Rituximab versus obinutuzumab-based first-line chemoimmunotherapy for follicular lymphoma—a real-world multicenter retrospective cohort study
Tamar Berger, Tzippy Shochat, Shlomzion Aumann, Boaz Nachmias, Neta Goldschmidt, Nurit Horesh, Reut Harel, Ariel Aviv, Ella Shmerts, Uri Abadi, Shai Shimony, Pia Raanani, Anat Gafter‑Gvili, Ronit Gurion
Real-world effectiveness of ixazomib combined with lenalidomide and dexamethasone in relapsed/refractory multiple myeloma: the REMIX study
M. Macro, C. Hulin, L. Vincent, A. Charvet-Rumpler, L. Benboubker, C. Calmettes, A.-M. Stoppa, K. Laribi, L. Clement-Filliatre, H. Zerazhi, F. Honeyman, V. Richez, F. Maloisel, L. Karlin, J. Barrak, C. Chouaid, X. Leleu
Clinicopathological analysis and specific discriminating markers of interleukin detection in cerebrospinal fluid with primary central nervous system lymphoma: results from a retrospective study
Junnan Li, Xiaoqiong Tang, Xiaohua Luo, Lin Liu, Dan Li, Li Yang
Prevalence and prognostic significance of IKZF1 deletion in paediatric acute lymphoblastic leukemia: A systematic review and meta-analysis
Shyam Srinivasan, Subramaniam Ramanathan, Shathish Kumar, Srinivasan Peyam, Venkatraman Radhakrishnan
Impacts of early therapy response, interval to therapy interruption, and cumulative therapy interruption duration on outcome of ibrutinib therapy in relapsed/refractory chronic lymphocytic leukemia
Shenmiao Yang, Nan Li, Rong Zhu, Yu Feng, Jianmin Zhuo, Robert Peter Gale, Xiaojun Huang
PD-1 blockade combined with ICE regimen in relapsed/refractory diffuse large B-cell lymphoma
Liqin Ping, Yan Gao, Yanxia He, Bing Bai, Cheng Huang, Lina Shi, Xiaoxiao Wang, Huiqiang Huang
Analysis of long-term mortality after total body irradiation-based and melphalan-based chemotherapy conditioning for acute myeloid leukemia
Isabella Gruber, Oliver Koelbl, Marius Treutwein, Florian Zeman, Wolfgang Herr, Ernst Holler, Matthias Edinger, Daniel Wolff
Impact of extramedullary disease in AML patients undergoing sequential RIC for HLA-matched transplantation: occurrence, risk factors, relapse patterns, and outcome
Alessia Fraccaroli, Daniela Vogt, Margarete Rothmayer, Karsten Spiekermann, Friederike Pastore, Johanna Tischer
Toxicity Profile According to Etoposide and Cytarabine Dosing in Patients with Lymphoma Receiving Autologous Stem Cell Transplantation Following BEAM Conditioning
Agathe Vely, Jérôme Paillassa, Christopher Nunes Gomes, Aurélien Giltat, Sophie Fouquet, Anne Lebreton, Marion Klemencie, Aline Clavert, Aline Tanguy-Schmidt, Mathilde Hunault-Berger, Corentin Orvain
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)
Mihee Kim, Je-Jung Lee, Chang-Ki Min, Ji Yun Lee, Jae-Cheol Jo, Sung-Soo Yoon, Sung-Nam Lim, Young Rok Do, Kihyun Kim, Jae Hoon Lee, Kwai Han Yoo, Sung Hwa Bae, Jun Ho Yi, Jongheon Jung, Hyeon-Seok Eom, Sung-Hoon Jung
Comparison of outcomes for patients with acute myeloid leukemia undergoing haploidentical stem cell transplantation in first and second complete remission
Wen-Jing Yu, Yu-qian Sun, Lan-Ping Xu, Xiao-Hui Zhang, Kai-Yan Liu, Xiao-Jun Huang, Yu Wang
Anti-Xa level monitoring of low-molecular-weight heparin during intermittent venovenous hemofiltration
Lengnan Xu, Ying Sun, Songlan Wang, Chuanbao Li, Yonghui Mao
Association between N-acetylcysteine treatment and in-hospital mortality in adult patients with acquired thrombotic thrombocytopenic purpura: a cohort study
Jing Li, You Zhang, Danqing Kong, Jian Su, Yao Wei, Xueke Liu, Shiqi Lu, Jun Wang, Fang Huang
Response to: meta-analysis on allogeneic transplant for treating pediatric patients with acute myeloid leukemia in first remission: reanalysis of primary data
Riccardo Masetti, Edoardo Muratore, Davide Gori, Arcangelo Prete, Franco Locatelli
Rare acquired factor V inhibitors combined with positive lupus anticoagulant that successfully treated by plasmapheresis and prednisone acetate: a typical case report
Ning Yu, Xiaojun Liu, Chao Liu, Wenbin Tian, Weihao Li, Ya Liu
Myomatous erythrocytosis syndrome—an uncommon cause of secondary polycythemia
Mariana de Oliveira Marques, Natalia Campos Gomes, Pedro de Andrade Young, Otávio de Oliveira Marques, Fábio Rodrigues Kerbauy, Alex Freire Sandes
Establishment of the Abu Dhabi Emirate Thalassemia Longitudinal Cohort (AD-TLC): leveraging the power of observation
Khaled M. Musallam, Wesam Ahmed, Mozah Obaid Almarshoodi, Omar Trad, Naser Al Zein, Shamyla Siddique, Nastaran Shekary, Sulaima Daboul, Shahrukh Hashmi
Leukemic form of high-grade B-cell lymphoma (HGBL) in a very elderly patient with multiple comorbidities: effective treatment of a very rare subtype with a mini-R-da-EPOCH version
Marina Belia, Ioannis Drandakis, Eleftheria Lakiotaki, Maria Arapaki, Fotios Panitsas, Evangelia-Fedra Triantafyllou, Eleni Plata, Marina P. Siakantaris, Maria K. Angelopoulou, Penelope Korkolopoulou, Theodoros P. Vassilakopoulos
Emergence of maribavir resistance after CMV treatment in hematopoietic stem cell transplant recipient
Julia Bini Viotti, Fabian Dammann, Antonio Martin Jimenez Jimenez, Anthony D. Anderson, Michele I. Morris, Jose F. Camargo, Mohammed Raja
CD200 expression in T cell neoplasms
Renata Bartolomeu Staub, Natália Aydos Marcondes, Bianca Michel Spindler, Flavo Beno Fernandes, Gustavo Adolpho Moreira Faulhaber, Liane Nanci Rotta
Acute liver failure associated with human adenovirus infection after allogeneic hematopoietic stem cell transplantation
Zhimin Lin, Yanjun Wu, Ye Zhao, Tingjing Wang, Jing Xia, Huiying Qiu, Zhengming Jin, Depei Wu, Feng Chen
Successful treatment with cyclosporine of pure red cell aplasia induced by obinutuzumab bendamustine therapy
Yutaka Shimazu, Chisaki Mizumoto, Kazuhisa Chonabayashi, Yuta Hanyu, Junya Kanda, Akifumi Takaori-Kondo
An adult case of systemic lupus erythematosus and cerebral vasculitis after umbilical cord blood transplantation for acute myeloid leukemia
Weiwei Xie, Zeyin Liang, Qian Wang, Bingjie Wang, Yue Yin, Yuan Li, Hanyun Ren, Yujun Dong
Correction to: Effectiveness of biosimilar pegfilgrastim in patients with multiple myeloma after high‑dose melphalan and autologous stem cell transplantation
Massimo Martino, Mercedes Gori, Gaetana Porto, Maria Pellicano, Ludovica Santoro, Chiara Verduci, Filippo Antonio Canale, Barbara Loteta, Tiziana Moscato, Caterina Alati, Maria Consuelo Ieracitano, Amelia Cuzzocrea, Maria Altomonte, Maria Teresa Florenzano, Antonella Morabito, Giuseppe Irrera, Virginia Naso, Marta Pugliese, Giuseppe Console, Anna Ferreri, Lucrezia Imbalzano, Giovanni Tripepi, Annalisa Pitino
Correction to: Venetoclax plus azacitidine compared with intensive chemotherapy as induction for patients with acute myeloid leukemia: retrospective analysis of an electronic medical record database in the United States
Amer M. Zeidan, Daniel A. Pollyea, Uma Borate, Alberto Vasconcelos, Ravi Potluri, David Rotter, Zephirin Kiendrebeogo, Lona Gaugler, Thomas Prebet, Maria Strocchia, Gaetano Bonifacio, Clara Chen